We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Analytical Cannabis Logo

Home > News > Policy

Alabama Legalizes Medical Cannabis

Published: May 18, 2021   

Complete the form below and we will email you a PDF version of "Alabama Legalizes Medical Cannabis"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Analytical Cannabis?

Analytical Cannabis Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Alabama Legalizes Medical Cannabis

Leo Bear-McGuinness
Science Writer & Editor

Alabama has become the latest US state to legalize medical cannabis.

On Monday, May 17 – just over a week since the state House and Senate approved a medical cannabis legalization bill – Governor Kay Ivey signed the bill into law.

The new program will allow patients who live with one of 16 qualifying medical conditions, including cancer, a terminal illness, and depression, to buy medical cannabis with the recommendation of a doctor.

In the bill

Alabama’s senate approved the bill in February by a 21-to-8 vote following 15 minutes of debate. The House of Representatives then sent the bill through two committees before approving it on May 6 by a 68-to-34 margin.

The bill permits the sale of medical cannabis in forms such as pills, skin patches, and creams, but not baked goods, smokables, or vaping products.

The daily THC dosage for these products will also be capped at 50 milligrams. However, this maximum dose may be exceeded to 75 milligrams in the case of terminal illness or if a higher dose is deemed medically appropriate by a doctor after 90 days of care.

According to the Associated Press, qualifying medical conditions for cannabis will include cancer-related nausea, chronic pain, Crohn’s disease, depression, epilepsy, HIV/AIDS-related nausea, panic disorder, Parkinson’s disease, persistent nausea, post-traumatic stress disorder, sickle cell anemia, spasticity associated with multiple sclerosis, spinal cord injury, and Tourette’s syndrome.

Under the bill, business license applications are expected to begin September 1, 2022.


Like what you just read? You can find similar content on the topic tags shown below.

Policy Science & Health

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter